SACCOMANO NICHOLAS A (President and CEO) sold 2.4% of their position (88.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $230.87 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/24/2025ACC: 0001609284-25-000003
DirectorOfficer· President and CEO
Since Oct 2024
-88.00
Net shares
Net seller
$230.87
Total sold
1
Open market trades
0B · 1S
1
Total transactions
88.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−88.00
Price / share
$2.62
Trade value
$230.87
% of position
2.4%
9/22/2025
3.59K→3.51K
Total
Net shares
−88.00
Net value
-$230.87
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/22/2025 | S · Sale | −88.00 | $2.62 | $230.87 | 2.4% | 3.59K | 3.51K |
| Total | −88.00 | -$230.87 | ||||||
Derivative Transactions0
No derivative transactions reported